PUBBLICAZIONI CLINICA METABOLICA
Pubblicazioni 2023
Le seguenti pubblicazioni sono state pubblicate nel corso dell’anno 2023
Bone Mineral Density and Trabecular Bone Score Changes throughout Menopause in Women with HIV.
Milic J, Renzetti S, Morini D, Motta F, Carli F, Menozzi M, Cuomo G, Mancini G, Simion M, Romani F, Spadoni A, Baldisserotto I, Barp N, Diazzi C, Mussi C, Mussini C, Rochira V, Calza S, Guaraldi G.
Viruses. 2023 Dec 1;15(12):2375. doi: 10.3390/v15122375.
Vancomycin resistant enterococcus risk factors for hospital colonization in hematological patients: a matched case-control study.
Meschiari M, Kaleci S, Monte MD, Dessilani A, Santoro A, Scialpi F, Franceschini E, Orlando G, Cervo A, Monica M, Forghieri F, Venturelli C, Ricchizzi E, Chester J, Sarti M, Guaraldi G, Luppi M, Mussini C.
Antimicrob Resist Infect Control. 2023 Nov 13;12(1):126. doi: 10.1186/s13756-023-01332-x.
A Machine Learning Approach to Predict Weight Change in ART-Experienced People Living With HIV.
Motta F, Milic J, Gozzi L, Belli M, Sighinolfi L, Cuomo G, Carli F, Dolci G, Iadisernia V, Burastero G, Mussini C, Missier P, Mandreoli F, Guaraldi G.
J Acquir Immune Defic Syndr. 2023 Dec 15;94(5):474-481. doi: 10.1097/QAI.0000000000003302.
Evaluating immunological and inflammatory changes of treatment- experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial.
Cossarizza A, Cozzi-Lepri A, Mattioli M, Paolini A, Neroni A, De Biasi S, Tartaro DL, Borella R, Fidanza L, Gibellini L, Beghetto B, Roncaglia E, Nardini G, Milic J, Menozzi M, Cuomo G, Digaetano M, Orlando G, Borghi V, Guaraldi G, Mussini C.
Front Immunol. 2023
Oct 16;14:1279390. doi: 10.3389/fimmu.2023.1279390.
The Association of Procalcitonin and C-Reactive Protein with Bacterial Infections Acquired during Intensive Care Unit Stay in COVID-19 Critically Ill Patients.
Campani S, Talamonti M, Dall'Ara L, Coloretti I, Gatto I, Biagioni E, Tosi M, Meschiari M, Tonelli R, Clini E, Cossarizza A, Guaraldi G, Mussini C, Sarti M, Trenti T, Girardis M; MO-COVID-19 Working Group.
Antibiotics
(Basel). 2023 Oct 12;12(10):1536. doi: 10.3390/antibiotics12101536.
Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023.
Ambrosioni J, Levi L, Alagaratnam J, Van Bremen K, Mastrangelo A, Waalewijn H, Molina JM, Guaraldi G, Winston A, Boesecke C, Cinque P, Bamford A, Calmy A, Marzolini C, Martínez E, Oprea C, Welch S, Koval A, Mendao L, Rockstroh JK; EACS Governing Board.
HIV Med. 2023 Nov;24(11):1126-1136. doi: 10.1111/hiv.13542. Epub 2023 Oct 18.
Can statin preventative treatment inform geroscience-guided therapeutics?
Guaraldi G, Erlandson KM, Milic J, Landay AL, Montano MA.
Aging Cell. 2023
Dec;22(12):e13998. doi: 10.1111/acel.13998. Epub 2023 Oct 13.
Sarcopenic Obesity Phenotypes in Patients With HIV: Implications for Cardiovascular Prevention and Rehabilitation.
Milic J, Calza S, Cantergiani S, Albertini M, Gallerani A, Menozzi M, Barp N, Todisco V, Renzetti S, Motta F, Mussini C, Sebastiani G, Raggi P, Guaraldi G.
Can J Cardiol. 2023 Nov;39(11S):S359-S367. doi: 10.1016/j.cjca.2023.08.027. Epub 2023 Sep 1.
Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort.
d'Arminio Monforte A, Tavelli A, Rossotti R, Gagliardini R, Saracino A, Lo Caputo S, Sala M, Quiros-Roldan E, Mussini C, Girardi E, Cozzi-Lepri A, Antinori A, Puoti M; NoCo Study of the Icona cohort.
Liver Int. 2023 Oct;43(10):2130-2141. doi: 10.1111/liv.15700. Epub 2023 Aug 31.
Pillars of long-term antiretroviral therapy success.
Taramasso L, Andreoni M, Antinori A, Bandera A, Bonfanti P, Bonora S, Borderi M, Castagna A, Cattelan AM, Celesia BM, Cicalini S, Cingolani A, Cossarizza A, D'Arminio Monforte A, D'Ettorre G, Di Biagio A, Di Giambenedetto S, Di Perri G, Esposito V, Focà E, Gervasoni C, Gori A, Gianotti N, Guaraldi G, Gulminetti R, Lo Caputo S, Madeddu G, Maggi P, Marandola G, Marchetti GC, Mastroianni CM, Mussini C, Perno CF, Rizzardini G, Rusconi S, Santoro M, Sarmati L, Zazzi M, Maggiolo F.
Pharmacol Res. 2023 Oct;196:106898. doi: 10.1016/j.phrs.2023.106898. Epub 2023 Aug 28.
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir.
González-Cordón A, Assoumou L, Moyle G, Waters L, Johnson M, Domingo P, Fox J, Stellbrink HJ, Guaraldi G, Masiá M, Gompels M, De Wit S, Florence E, Esser S, Raffi F, Behrens G, Pozniak A, Gatell JM, Martínez E; NEAT 022 Study Group.
J Antimicrob Chemother. 2023 Sep 5;78(9):2361-2365. doi: 10.1093/jac/dkad247.
Critical COVID-19 patients through first, second, and third wave: retrospective observational study comparing outcomes in intensive care unit.
Coloretti I, Farinelli C, Biagioni E, Gatto I, Munari E, Dall'Ara L, Busani S, Meschiari M, Tonelli R, Mussini C, Guaraldi G, Cossarizza A, Clini E, Girardis M; MO-COVID19 Working Group.
J Thorac Dis. 2023 Jun 30;15(6):3218-3227. doi:
10.21037/jtd-22-764. Epub 2023 May 26.
Moving from the prediction of fractures to the prediction of falls in an aging HIV scenario.
Milic J, Erlandson KM, Guaraldi G.
AIDS. 2023 Jul 15;37(9):1467-1469. doi: 10.1097/QAD.0000000000003606.
Epidemiology and Prevention of Early Infections by Multi-Drug-Resistant Organisms in Adults Undergoing Liver Transplant: A Narrative Review.
Dolci G, Burastero GJ, Paglia F, Cervo A, Meschiari M, Guaraldi G, Chester J, Mussini C, Franceschini E.
Microorganisms. 2023 Jun 17;11(6):1606. doi: 10.3390/microorganisms11061606.
Quality of life and intrinsic capacity in patients with post-acute COVID-19 syndrome is in relation to frailty and resilience phenotypes.
Guaraldi G, Milic J, Barbieri S, Marchiò T, Caselgrandi A, Motta F, Beghè B, Verduri A, Belli M, Gozzi L, Iadisernia V, Faltoni M, Burastero G, Dessilani A, Del Monte M, Dolci G, Bacca E, Franceschi G, Yaacoub D, Volpi S, Mazzochi A, Clini E, Mussini C.
Sci Rep. 2023 Jun 2;13(1):8956. doi: 10.1038/s41598-023-29408-z.
Prognostic immune markers identifying patients with severe COVID-19 who respond to tocilizumab.
De Biasi S, Mattioli M, Meschiari M, Lo Tartaro D, Paolini A, Borella R, Neroni A, Fidanza L, Busani S, Girardis M, Coppi F, Mattioli AV, Guaraldi G, Mussini C, Cossarizza A, Gibellini L.
Front Immunol. 2023 May 5;14:1123807. doi: 10.3389/fimmu.2023.1123807.
Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial.
Sempere A, Assoumou L, González-Cordón A, Waters L, Rusconi S, Domingo P, Gompels M, de Wit S, Raffi F, Stephan C, Masiá M, Rockstroh J, Katlama C, Behrens GMN, Moyle G, Johnson M, Fox J, Stellbrink HJ, Guaraldi G, Florence E, Esser S, Gatell J, Pozniak A, Martínez E; NEAT 022 Study Group.
Clin Infect Dis. 2023 Oct 5;77(7):991-1009. doi: 10.1093/cid/ciad297.
Letter to the Editor: People living with HIV and NAFLD-A population left behind in the global effort for liver fibrosis screening?
Sebastiani G, Milic J, Tsochatzis EA, Marzolini C, Betel M, Bhagani S, Morse CG, Cinque F, Maurice JB, Ingiliz P, Price J, Lemoine M, Rockstroh JK, Guaraldi G; Steatohepatitis in HIV Emerging Research (SHIVER) Network.
Hepatology. 2023 Nov 1;78(5):E87-E88. doi: 10.1097/HEP.0000000000000465. Epub 2023 May 19.
Prognostic value of non-invasive scores based on liver stiffness measurement, spleen diameter and platelets in HIV- infected patients.
Benmassaoud A, Macias J, Delamarre A, Corma-Gomez A, Guaraldi G, Milic J, Rockstroh JK, Van Bremen K, Tsochatzis E, Mulay A, Price J, Garvey LJ, Lemoine M, Kablawi D, Lebouche B, Klein MB, Ballesteros LR, Boesecke C, Schepis F, Bhagani S, Cooke G, Berzigotti A, Hirose K, Pineda JA, Ramanakumar AV, De- Ledinghen V, Saeed S, Sebastiani G.
Liver Int. 2023 Jul;43(7):1427-1439. doi: 10.1111/liv.15605. Epub 2023 May 15.
Nutritional and Lifestyle Therapy for NAFLD in People with HIV.
Cinque F, Cespiati A, Lombardi R, Guaraldi G, Sebastiani G.
Nutrients. 2023 Apr 20;15(8):1990. doi: 10.3390/nu15081990.
Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab.
Franceschini E, Pellegrino M, Todisco V, Dolci G, Bettelli F, Meschiari M, Bedini A, Fregni-Serpini G, Grottola A, Guaraldi G, Pecorari M, Sarti M, Luppi M, Perno CF, Mussini C.
Infection. 2023 Oct;51(5):1577-1581. doi: 10.1007/s15010-023-02039-2. Epub 2023 Apr 19.
Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda.
Guaraldi G, Bonfanti P, Di Biagio A, Gori A, Milić J, Saltini P, Segala FV, Squillace N, Taramasso L, Cingolani A.
BMC Infect Dis. 2023 Apr 14;23(1):230. doi: 10.1186/s12879-023-08174-3.
Comparing implications of cardiovascular risk of abacavir and integrase inhibitors: why scientific community is confused and timid?
Guaraldi G, Milic J.
AIDS. 2023 May 1;37(6):1005-1008. doi: 10.1097/QAD.0000000000003518.
Fibroscan-Aspartate Aminotransferase Score Predicts Liver-Related Outcomes, but Not Extrahepatic Events, in a Multicenter Cohort of People With Human Immunodeficiency Virus.
Sebastiani G, Milic J, Kablawi D, Gioè C, Al Hinai AS, Lebouché B, Tsochatzis E, Finkel J, Ballesteros LR, Ramanakumar AV, Bhagani S, Benmassaoud A, Mazzola G, Cascio A, Guaraldi G.
Clin Infect Dis. 2023 Aug 14;77(3):396-404. doi: 10.1093/cid/ciad203.
Practical management of complexity in older people with HIV: approaching an international consensus.
Barber TJ, Crabtree B, Cortes CP, Guaraldi G, Hoy JF, Rajasuriar R, Castilho J, Agosto-Rosario M, Murzin K, Falutz J.
AIDS Care. 2023 Aug;35(8):1149-1153. doi: 10.1080/09540121.2023.2190956. Epub 2023 Mar 30.
Successful living donor liver transplantation from an HIV and HCV positive donor: report from the first case in the world.
Di Sandro S, Catellani B, Guidetti C, Magistri P, Ballarin R, Pecchi A, Caracciolo D, Guaraldi G, Guerrini GP, Di Benedetto F.
AIDS. 2023 Jul 1;37(8):1257-1261. doi: 10.1097/QAD.0000000000003533. Epub 2023 Mar 3.
Long-term success for people living with HIV: A framework to guide practice.
Lazarus JV, Wohl DA, Cascio M, Guaraldi G, Rockstroh J, Hodson M, Richman B, Brown G, Anderson J, Fuster-RuizdeApodaca MJ.
HIV Med. 2023 Mar;24 Suppl 2:8-19. doi: 10.1111/hiv.13460.
Why we need to re-define long-term success for people living with HIV.
Fuster-RuizdeApodaca MJ, Wohl DA, Cascio M, Guaraldi G, Rockstroh J, Hodson M, Richman B, Brown G, Anderson J, Lazarus JV.
HIV Med. 2023 Mar;24 Suppl 2:3-7. doi: 10.1111/hiv.13461.
BEING: Bone Health in Aging Women with HIV: Impact of Switching Antiretroviral Therapy on Bone Mineral Density During the Perimenopausal Period.
Walmsley S, Clarke R, Lee T, Singer J, Cheung AM, Smaill F, De Pokomandy A, Trottier S, Messina E, Guaraldi G.
AIDS Res Hum Retroviruses. 2023 Apr;39(4):204-210. doi: 10.1089/AID.2022.0106. Epub 2023 Jan 20.
Drug treatment of COVID-19 infection.
Lui G, Guaraldi G.
Curr Opin Pulm Med. 2023 May 1;29(3):174-183. doi: 10.1097/MCP.0000000000000953. Epub 2023 Mar 14.
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study.
D'arminio Monforte A, Tavelli A, Sala M, Mondi A, Rusconi S, Antinori S, Puoti M, Celesia BM, Taramasso L, Saracino A, Antinori A, Cozzi-Lepri A; ICONA Foundation Study Group.
J Antimicrob Chemother. 2023 Apr 3;78(4):933-945. doi: 10.1093/jac/dkad026.
Impact of coronavirus disease 2019 on co-morbidities in HIV.
Guaraldi G, Milic J.
Curr Opin HIV AIDS. 2023 Mar 1;18(2):111-115. doi: 10.1097/COH.0000000000000785.
External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection.
Surial B, Ramírez Mena A, Roumet M, Limacher A, Smit C, Leleux O, Mocroft A, van der Valk M, Bonnet F, Peters L, Rockstroh JK, Günthard HF, Berzigotti A, Rauch A, Wandeler G; Swiss HIV Cohort Study; ATHENA Observational Cohort Study; EuroSIDA; ANRS CO3 Aquitaine Cohort
J Hepatol. 2023 May;78(5):947-957. doi: 10.1016/j.jhep.2022.12.029. Epub 2023 Jan 21.
Hepatitis delta infection among persons living with HIV in Europe.
Béguelin C, Atkinson A, Boyd A, Falconer K, Kirkby N, Suter-Riniker F, Günthard HF, Rockstroh JK, Mocroft A, Rauch A, Peters L, Wandeler G; for EuroSIDA and SHCS.
Liver Int. 2023 Apr;43(4):819-828. doi: 10.1111/liv.15519. Epub 2023 Jan 21.
Determinants of sexual function in men living with HIV younger than 50 years old: Focus on organic, relational, and psychological issues.
De Vincentis S, Decaroli MC, Milic J, Fanelli F, Tartaro G, Diazzi C, Mezzullo M, De Santis MC, Roli L, Trenti T, Santi D, Pagotto U, Guaraldi G, Rochira V.
Andrology. 2023 Sep;11(6):954-969. doi: 10.1111/andr.13372. Epub 2023 Jan 12.
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study. Viruses.
Mussini C, Cozzi-Lepri A, Meschiari M, Franceschini E, Burastero G, Faltoni M, Franceschi G, Iadisernia V, Volpi S, Dessilani A, Gozzi L, Conti J, Del Monte M, Milic J, Borghi V, Tonelli R, Brugioni L, Romagnoli E, Pietrangelo A, Corradini E, Girardis M, Busani S, Cossarizza A, Clini E, Guaraldi G.
Viruses. 2023 Jan 20;15(2):294. doi: 10.3390/v15020294.
Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination.
Lo Tartaro D, Paolini A, Mattioli M, Swatler J, Neroni A, Borella R, Santacroce E, Di Nella A, Gozzi L, Busani S, Cuccorese M, Trenti T, Meschiari M, Guaraldi G, Girardis M, Mussini C, Piwocka K, Gibellini L, Cossarizza A, De Biasi S.
Front Immunol. 2023 Feb 9;14:1123724. doi: 10.3389/fimmu.2023.1123724.
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial.
Waters L, Assoumou L, González-Cordón A, Rusconi S, Domingo P, Gompels M, de Wit S, Raffi F, Stephan C, Masiá M, Rockstroh J, Katlama C, Behrens GMN, Moyle G, Johnson M, Fox J, Stellbrink HJ, Guaraldi G, Florence E, Esser S, Gatell JM, Pozniak A, Martínez E; NEAT 022 Study Group.
Clin Infect Dis. 2023 Mar 4;76(5):861-870. doi: 10.1093/cid/ciac827.
Prevalence of and risk factors for pubic lipoma development in HIV-infected persons.
Guaraldi G, Orlando G, Squillace N, Roverato A, De Fazio D, Vandelli M, Nardini G, Beghetto B, De Paola M, Esposito R, Palella F.
J Acquir Immune Defic Syndr. 2007 May 1;45(1):72-6.
TUTTE LE NOSTRE PUBBLICAZIONI
Siamo lieti
di accoglierti
Chiedici informazioni
o prenota la tua prima visita
presso la Clinica Metabolica
di Modena